Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chickenpox Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03820414
What this trial is testing

Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult Subjects

Who this might be right for
Herpes ZosterVaricella Zoster
Curevo Inc 90
Large-scale testing (Phase 3)Study completedNCT04334577
What this trial is testing

Study on Efficacy of Attenuated Zoster Vaccine, Live

Who this might be right for
Herpes Zoster
Changchun BCHT Biotechnology Co. 25,000
Large-scale testing (Phase 3)Study completedNCT02062502
What this trial is testing

Evaluation of Immunogenicity and Safety of VARIVAX™ New Seed Process (NSP) in Children (V210-063)

Who this might be right for
Varicella
Merck Sharp & Dohme LLC 611
Post-approval studies (Phase 4)UnknownNCT01866566
What this trial is testing

The Safety and Immunogenicity Research of Live Attenuated Varicella Vaccine After the 2 Doses Vaccination

Who this might be right for
Varicella
Beijing Center for Disease Control and Prevention 1,800
Not applicableStudy completedNCT01160081
What this trial is testing

Seroprevalence Study of Hepatitis A, Varicella-Zoster, Cytomegalovirus, Herpes Simplex and Bordetella Pertussis

Who this might be right for
Viral Hepatitis VaccinesHepatitis ACytomegalovirus+3 more
GlaxoSmithKline 3,658
Early research (Phase 1)Study completedNCT01262300
What this trial is testing

Vitamin D Supplementation And Varicella Zoster Virus Vaccine Responsiveness In Older Long-Term Care Residents

Who this might be right for
ImmunosenescenceShingles
University of Colorado, Denver 33
Testing effectiveness (Phase 2)Looking for participantsNCT05554068
What this trial is testing

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
Shingles
Loyola University 100
Large-scale testing (Phase 3)Study completedNCT00322231
What this trial is testing

An Investigational Zoster Vaccine, in Subjects With a History of Herpes Zoster (V211-014)

Who this might be right for
Herpes Zoster
Merck Sharp & Dohme LLC 101
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Large-scale testing (Phase 3)Study completedNCT05158777
What this trial is testing

Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Healthy Population Aged ≥13 Years Old

Who this might be right for
Varicella
Shanghai Institute Of Biological Products 2,480
Large-scale testing (Phase 3)Study completedNCT03239873
What this trial is testing

Evaluation of Immunogenicity and Safety of VARIVAX® Passage Extension 34 (PE34) Process in Children (V210-A03)

Who this might be right for
Varicella
Merck Sharp & Dohme LLC 600
Testing effectiveness (Phase 2)Study completedNCT05084508
What this trial is testing

A Study on the Immune Response and Safety of Various Potencies of an Investigational Chickenpox Vaccine Compared With a Marketed Chickenpox Vaccine, Given to Healthy Children 12 to 15 Months of Age

Who this might be right for
Chickenpox
GlaxoSmithKline 800
Large-scale testing (Phase 3)Looking for participantsNCT07054099
What this trial is testing

Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Years

Who this might be right for
Varicella (Chickenpox)Chickenpox Vaccine
GC Biopharma Corp 474
Large-scale testing (Phase 3)Study completedNCT00422292
What this trial is testing

Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers

Who this might be right for
Meningococcal MeningitisMeaslesMumps+2 more
Sanofi Pasteur, a Sanofi Company 1,664
Large-scale testing (Phase 3)Study completedNCT00213304
What this trial is testing

The Safety of Oka Varicella in Children Prior to Solid Organ Transplantation

Who this might be right for
Organ TransplantationImmunosuppression
The Hospital for Sick Children 21
Testing effectiveness (Phase 2)Study completedNCT00568334
What this trial is testing

Study of Two Formulations of GSK Biologicals' Varicella Vaccine

Who this might be right for
Varicella
GlaxoSmithKline 244
Large-scale testing (Phase 3)Study completedNCT06614816
What this trial is testing

Immunogenicity and Safety of a Live Attenuated Varicella Vaccine in Children Aged 1-12 Years

Who this might be right for
Chickenpox Vaccines
Southeast University, China 1,200
Not applicableStudy completedNCT03239665
What this trial is testing

Vaccination Education Through Pharmacists and Senior Centers (VEPSC)

Who this might be right for
Infectious DiseasePneumonia, BacterialInfluenza+1 more
Rutgers, The State University of New Jersey 335
Large-scale testing (Phase 3)UnknownNCT06001606
What this trial is testing

Immunogenicity, Reactogenicity of Shingrix in SLE

Who this might be right for
ZosterSystemic Lupus ErythematosusVaccine Reaction
Seoul National University Hospital 63
Testing effectiveness (Phase 2)Looking for participantsNCT05580458
What this trial is testing

Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population

Who this might be right for
Herpes Zoster
National Institute of Allergy and Infectious Diseases (NIAID) 225
Next Page